Stage II Adult T-Cell Leukemia/Lymphoma Completed Phase 2 Trials for Deferasirox (DB01609)

IndicationStatusPhase
DBCOND0036553 (Stage II Adult T-Cell Leukemia/Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01273766Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesSupportive Care